Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Treatment Completion Rate Between Conventional and Dose-dense Doxorubicin and Cyclophosphamide (AC) Followed by a Taxane in Patients With Breast Cancer: A Propensity Score-matched Analysis.
Mamishin K, Naito Y, Nomura S, Ogawa G, Niguma K, Baba K, Sakaeda S, Nakajima H, Kusuhara S, Funasaka C, Nakao T, Fukasawa Y, Kondoh C, Harano K, Kogawa T, Matsubara N, Hosono A, Kawasaki T, Mukohara T. Mamishin K, et al. Among authors: fukasawa y. Anticancer Res. 2021 Dec;41(12):6217-6224. doi: 10.21873/anticanres.15441. Anticancer Res. 2021. PMID: 34848476
Impact of Older Age and Medico-social Factors on the Decision to Offer Adjuvant Chemotherapy to Patients With Breast Cancer.
Niguma K, Mamishin K, Naito Y, Nomura S, Wakabayashi M, Kusuhara S, Funasaka C, Nakao T, Fukasawa Y, Kondoh C, Harano K, Kogawa T, Matsubara N, Hosono A, Onishi T, Kawasaki T, Mukohara T. Niguma K, et al. Among authors: fukasawa y. Anticancer Res. 2022 Jul;42(7):3743-3751. doi: 10.21873/anticanres.15864. Anticancer Res. 2022. PMID: 35790267
Effects of Ado-Trastuzumab Emtansine and Fam-Trastuzumab Deruxtecan on Metastatic Breast Cancer Harboring HER2 Amplification and the L755S Mutation.
Mukohara T, Hosono A, Mimaki S, Nakayama A, Kusuhara S, Funasaka C, Nakao T, Fukasawa Y, Kondoh C, Harano K, Naito Y, Matsubara N, Tsuchihara K, Kuwata T. Mukohara T, et al. Among authors: fukasawa y. Oncologist. 2021 Aug;26(8):635-639. doi: 10.1002/onco.13715. Epub 2021 Mar 11. Oncologist. 2021. PMID: 33559918 Free PMC article.
Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature Review.
Ota S, Sakamoto T, Ochiai R, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Tanzawa S, Usui R, Honda T, Ichikawa Y, Watanabe K, Sasajima Y, Mizota A, Seki N. Ota S, et al. Among authors: fukasawa y. Case Rep Oncol. 2019 Jan 11;12(1):47-52. doi: 10.1159/000493850. eCollection 2019 Jan-Apr. Case Rep Oncol. 2019. PMID: 30792644 Free PMC article.
Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush.
Seki N, Ochiai R, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ota S, Ichikawa Y, Watanabe K. Seki N, et al. Among authors: fukasawa y. Case Rep Oncol. 2019 Jan 21;12(1):84-90. doi: 10.1159/000493256. eCollection 2019 Jan-Apr. Case Rep Oncol. 2019. PMID: 30792647 Free PMC article.
Importance and Difficulty of Differentiating BMA-induced AFF Prodromal Symptoms from Hormonal Therapy-related Femoral Pain.
Ota S, Tokizaki T, Sugimoto M, Ochiai R, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ichikawa Y, Watanabe K, Kawano H, Seki N. Ota S, et al. Among authors: fukasawa y. Intern Med. 2020 Mar 15;59(6):855-857. doi: 10.2169/internalmedicine.3157-19. Epub 2019 Nov 22. Intern Med. 2020. PMID: 31761883 Free PMC article.
Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis.
Fukasawa Y, Sasaki K, Natsume M, Nakashima M, Ota S, Watanabe K, Takahashi Y, Kondo F, Kozuma K, Seki N. Fukasawa Y, et al. Case Rep Oncol. 2017 Sep 6;10(3):809-812. doi: 10.1159/000479958. eCollection 2017 Sep-Dec. Case Rep Oncol. 2017. PMID: 29070994 Free PMC article.
A Case of Advanced Submandibular Gland Cancer in Which Increased Prostate-Specific Antigen and Multiple Bone Metastases Wrongly Suggested Concurrent Prostate Cancer.
Fukasawa Y, Honda T, Natsume M, Haruyama T, Ishihara M, Sakamoto T, Usui R, Tanzawa S, Ota S, Ichikawa Y, Watanabe K, Saito K, Seki N. Fukasawa Y, et al. Case Rep Oncol. 2017 Dec 20;10(3):1127-1130. doi: 10.1159/000484975. eCollection 2017 Sep-Dec. Case Rep Oncol. 2017. PMID: 29430238 Free PMC article.
191 results